PACS Group director sells 236K shares under plan
PACS Group, Inc. director and co-founder Mark Hancock reported open-market sales of company common stock.
Rhea-AI Filing Summary
PACS Group, Inc. director and co-founder Mark Hancock reported open-market sales of company common stock. Across four transactions on June 15–16, 2026, he sold a total of 236,320 shares, including 83,066 shares at a weighted average price of $35.9038 per share and 134,093 shares at $36.2341 per share.
The filing states these sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026, indicating they were scheduled in advance. After these transactions, Hancock directly owned 54,366,277 shares of PACS Group common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 83,066 | $35.9038 | $2.98M |
| Sale | Common Stock | 134,093 | $36.2341 | $4.86M |
| Sale | Common Stock | 19,138 | $37.0543 | $709K |
| Sale | Common Stock | 23 | $37.8756 | $871.14 |
Footnotes (4)
- F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.
- F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $35.84 to $36.835 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $36.84 to $37.445 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $35.62 to $36.49 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
open-market sale financial
Common Stock financial
ten percent owner regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did PACS (PACS Group, Inc.) report in this Form 4?
Was the PACS Group (PACS) insider sale made under a Rule 10b5-1 trading plan?
What is Mark Hancock’s role at PACS Group (PACS) mentioned in the Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.